For a substantial portion of patients experiencing long COVID and new-onset chest pain, ischemia with nonobstructive coronary arteries (INOCA) appears to be the underlying cause of their angina, ...
Please provide your email address to receive an email when new articles are posted on . Six primary prevention risk assessment scores, including the Framingham risk score, Atherosclerotic ...
CHICAGO, IL—Intensive medical therapy (IMT), compared with usual care, fails to reduce the risk of cardiovascular events at 5 years in women who have ischemia with nonobstructive coronary arteries ...
Please provide your email address to receive an email when new articles are posted on . RANCHO PALOS VERDES, Calif. — Observational studies show ischemia with no obstructive CAD is “common” among ...
Empagliflozin reduced proinflammatory cytokines and oxidative stress markers in INOCA patients with CMD, improving vascular health. Treatment led to favorable shifts in endothelial extracellular ...
CHICAGO -- Coming this weekend, the American College of Cardiology (ACC) annual conference will feature research exploring new frontiers for GLP-1 drugs in cardiovascular medicine, and foundational ...
CHICAGO -- The WARRIOR trial was not able to prove that intensive medical therapy reduced major adverse cardiovascular events (MACE) in women with ischemia but no obstructive disease. For symptomatic ...
Consider almost everything you know about heart disease, particularly the garden-variety type involving high cholesterol levels, clogged coronary arteries, stents and bypass surgeries. Now I want you ...
Ischemia with No Obstructive Coronary Arteries (INOCA) and Myocardial Infarction with No Obstructive Coronary Arteries (MINOCA) are two underdiagnosed, potentially fatal forms of heart disease that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback